Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	May 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Market Capitalization	174	216	113	35	44	113
Market Cap Growth	91.16%	91.16%	221.19%	-19.99%	-61.12%	200.36%
Enterprise Value	-54	-48	98	-19	-14	49
Last Close Price	2.24	3.19	4.02	2.47	3.09	7.98
PS Ratio	99.26	148.28	78.65	6.49	-	11.23
PB Ratio	0.54	0.74	1.50	0.64	0.72	1.68
P/TBV Ratio	0.70	0.90	147.82	0.64	0.72	1.68
EV/Sales Ratio	-	-	68.42	-	-	4.86
Debt / Equity Ratio	0.01	0.01	0.03	-	0.01	0.01
Asset Turnover	0.01	0.01	0.02	-	-	0.25
Inventory Turnover	-	-	-	-	-	6.07
Quick Ratio	12.53	12.53	0.67	14.47	25.38	36.58
Current Ratio	12.68	12.68	1.08	17.07	26.18	37.37
Return on Equity (ROE)	-42.82%	-42.82%	-57.70%	-	-9.79%	-9.26%
Return on Assets (ROA)	-19.02%	-19.02%	-32.81%	-	-5.95%	-5.43%
Return on Capital (ROIC)	-22.42%	-22.42%	-38.66%	-	-6.17%	-5.73%
Earnings Yield	-46.96%	-36.77%	-41.23%	-30.64%	-16.57%	-3.00%
FCF Yield	-43.06%	-33.72%	-33.68%	-30.42%	-18.17%	-2.85%
Buyback Yield / Dilution	-140.72%	-140.72%	-88.38%	-0.06%	-36.73%	-53.61%

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q